![](/img/cover-not-exists.png)
PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA
JC Sambrook, AR Levy, K Osenenko, C Kindundu, M BarbeauVolume:
10
Year:
2007
Language:
english
DOI:
10.1016/s1098-3015(10)68895-x
File:
PDF, 86 KB
english, 2007